Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
411.00
+5.00 (1.23%)
Apr 14, 2026, 5:29 PM CET
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 1,862 employees as of December 31, 2025. The number of employees increased by 56 or 3.10% compared to the previous year.
Employees
1,862
Change
56
Growth
3.10%
Revenue / Employee
15.17M SEK
Profits / Employee
256.71K SEK
Market Cap
140.34B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,862 | 56 | 3.10% |
| Sep 30, 2025 | 1,890 | 76 | 4.19% |
| Jun 30, 2025 | 1,937 | 165 | 9.31% |
| Mar 31, 2025 | 1,895 | 143 | 8.16% |
| Dec 31, 2024 | 1,806 | 66 | 3.79% |
| Sep 30, 2024 | 1,814 | 23 | 1.28% |
| Jun 30, 2024 | 1,772 | -21 | -1.17% |
| Mar 31, 2024 | 1,752 | 140 | 8.68% |
| Dec 31, 2023 | 1,740 | 184 | 11.83% |
| Sep 30, 2023 | 1,791 | 236 | 15.18% |
| Jun 30, 2023 | 1,793 | 239 | 15.38% |
| Mar 31, 2023 | 1,612 | 43 | 2.74% |
| Dec 31, 2022 | 1,556 | -3 | -0.19% |
| Sep 30, 2022 | 1,555 | 23 | 1.50% |
| Jun 30, 2022 | 1,554 | 17 | 1.11% |
| Mar 31, 2022 | 1,569 | 61 | 4.05% |
| Dec 31, 2021 | 1,559 | 50 | 3.31% |
| Sep 30, 2021 | 1,532 | 61 | 4.15% |
| Jun 30, 2021 | 1,537 | 115 | 8.09% |
| Mar 31, 2021 | 1,508 | 108 | 7.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 238 |
| Orexo AB | 74 |
| EQL Pharma AB | 55 |
| Cinclus Pharma Holding AB | 21 |
| Enzymatica AB | 20 |
| Nanexa AB | 15 |
| Cereno Scientific AB | 10 |
| Moberg Pharma AB | 5 |
Swedish Orphan Biovitrum AB News
- 4 days ago - Health Canada Approves Swedish Orphan Biovitrum's EMPAVELI In C3G And Primary IC-MPGN Kidney Disease - Nasdaq
- 18 days ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 7 months ago - 10 stocks to consider if you want alternatives to the expensive S&P 500 - Market Watch
- 1 year ago - Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 2 years ago - Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 2 years ago - Bulletin from Swedish Orphan Biovitrum (Sobi)'s Extraordinary General Meeting (EGM) - PRNewsWire
- 3 years ago - New number of shares and votes in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 3 years ago - Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing - PRNewsWire